SOLEUS CAPITAL MANAGEMENT, L.P. Holdings

SOLEUS CAPITAL MANAGEMENT, L.P. is an investment fund managing more than 735.97M US dollars. The largest holdings include United Therapeutics, IVERIC bio and EDAP TMS S.A.. In Q3 2022 the fund bought assets of total value of 301.1M US dollars and sold assets of total value of 186.41M US dollars.

$735.96M

portfolio value

+5.17%

quarter

-40.94%

1 year

SOLEUS CAPITAL MANAGEMENT, L.P. portfolio changes

Portfolio changes (number of shares)
Period	Buy	Sel
Q1 2020	21234000	34961000
Q2 2020	98428000	17186000
Q3 2020	81011000	56180000
Q4 2020	215893000	59173000
Q1 2021	168245000	16856000
Q2 2021	240836000	137609000
Q3 2021	144117000	146218000
Q4 2021	286503000	134541000
Q1 2022	155399000	191142000
Q2 2022	163902000	180934000
Q3 2022	301100000	186405000

SOLEUS CAPITAL MANAGEMENT, L.P. 13F holdings

Stock	Position type	Portfolio share	Portfolio value	Avg. open price	Current price	P/L	Last change
Biotechnology United Therapeutics Corporation Portfolio share: 6.68% Portfolio value: 49.17M Avg. open price: $205.81 Current price: $273.72 P/L: +33.00% Sold -20.53% shares Q3 2022	share	6.68%	49.17M	$205.81	$273.72	+33.00%	Sold -20.53% shares Q3 2022
Biotechnology IVERIC bio, Inc. Portfolio share: 6.10% Portfolio value: 44.89M Avg. open price: $8.21 Current price: $21.89 P/L: +166.69% Bought +173.70% shares Q3 2022	share	6.10%	44.89M	$8.21	$21.89	+166.69%	Bought +173.70% shares Q3 2022
Medical Devices EDAP TMS S.A. Portfolio share: 5.48% Portfolio value: 40.34M Avg. open price: $7.62 Current price: $11.01 P/L: +44.45% Bought +48.89% shares Q3 2022	share	5.48%	40.34M	$7.62	$11.01	+44.45%	Bought +48.89% shares Q3 2022
Household & Personal Products The Beauty Health Company Portfolio share: 4.27% Portfolio value: 31.43M Avg. open price: $16.88 Current price: $11.03 P/L: -34.66% Sold -18.62% shares Q3 2022	share	4.27%	31.43M	$16.88	$11.03	-34.66%	Sold -18.62% shares Q3 2022
Diagnostics & Research Illumina, Inc. Portfolio share: 3.93% Portfolio value: 28.92M Avg. open price: N/A Current price: $213.86 P/L: N/A N/A Q3 2022	share	3.93%	28.92M	N/A	$213.86	N/A	N/A Q3 2022
Healthcare Plans CVS Health Corporation Portfolio share: 3.70% Portfolio value: 27.26M Avg. open price: $98.27 Current price: $102.01 P/L: +3.81% Bought +30.31% shares Q3 2022	share	3.70%	27.26M	$98.27	$102.01	+3.81%	Bought +30.31% shares Q3 2022
Biotechnology BioAtla, Inc. Portfolio share: 3.56% Portfolio value: 26.18M Avg. open price: $4.67 Current price: $10.52 P/L: +125.50% Bought +4.22% shares Q3 2022	share	3.56%	26.18M	$4.67	$10.52	+125.50%	Bought +4.22% shares Q3 2022
Drug Manufacturers—General Eli Lilly and Company Portfolio share: 3.55% Portfolio value: 26.12M Avg. open price: N/A Current price: $369.29 P/L: N/A N/A Q3 2022	share	3.55%	26.12M	N/A	$369.29	N/A	N/A Q3 2022
Diagnostics & Research Charles River Laboratories International, Inc. Portfolio share: 3.45% Portfolio value: 25.40M Avg. open price: N/A Current price: $215.11 P/L: N/A N/A Q3 2022	share	3.45%	25.40M	N/A	$215.11	N/A	N/A Q3 2022
Medical Devices Surmodics, Inc. Portfolio share: 3.17% Portfolio value: 23.36M Avg. open price: $49.09 Current price: $35.6 P/L: -27.48% Bought +16.26% shares Q3 2022	share	3.17%	23.36M	$49.09	$35.6	-27.48%	Bought +16.26% shares Q3 2022
Biotechnology Arcellx, Inc. Portfolio share: 3.16% Portfolio value: 23.27M Avg. open price: $18.08 Current price: $19.45 P/L: +7.58% Bought +36.29% shares Q3 2022	share	3.16%	23.27M	$18.08	$19.45	+7.58%	Bought +36.29% shares Q3 2022
Drug Manufacturers—Specialty & Generic Organogenesis Holdings Inc. Portfolio share: 2.86% Portfolio value: 21.02M Avg. open price: $8.75 Current price: $2.63 P/L: -69.94% Bought +22.76% shares Q3 2022	share	2.86%	21.02M	$8.75	$2.63	-69.94%	Bought +22.76% shares Q3 2022
Medical Devices IRADIMED CORP Portfolio share: 2.80% Portfolio value: 20.58M Avg. open price: $30.32 Current price: $28.57 P/L: -5.77% Bought +10.30% shares Q3 2022	share	2.80%	20.58M	$30.32	$28.57	-5.77%	Bought +10.30% shares Q3 2022
Medical Devices Tandem Diabetes Care, Inc. Portfolio share: 2.70% Portfolio value: 19.86M Avg. open price: $59.19 Current price: $42.44 P/L: -28.30% Bought +125.90% shares Q3 2022	share	2.70%	19.86M	$59.19	$42.44	-28.30%	Bought +125.90% shares Q3 2022
Biotechnology Theratechnologies Inc. Portfolio share: 2.58% Portfolio value: 18.97M Avg. open price: $3.41 Current price: $1.29 P/L: -62.17% Bought +2.37% shares Q3 2022	share	2.58%	18.97M	$3.41	$1.29	-62.17%	Bought +2.37% shares Q3 2022
Medical Instruments & Supplies Envista Holdings Corporation Portfolio share: 2.14% Portfolio value: 15.74M Avg. open price: N/A Current price: $33.51 P/L: N/A N/A Q3 2022	share	2.14%	15.74M	N/A	$33.51	N/A	N/A Q3 2022
Biotechnology Krystal Biotech, Inc. Portfolio share: 1.96% Portfolio value: 14.45M Avg. open price: $60.8 Current price: $75.78 P/L: +24.64% Sold -3.33% shares Q3 2022	share	1.96%	14.45M	$60.8	$75.78	+24.64%	Sold -3.33% shares Q3 2022
Biotechnology C4 Therapeutics, Inc. Portfolio share: 1.72% Portfolio value: 12.64M Avg. open price: $17.62 Current price: $8.28 P/L: -53.01% Bought +410.02% shares Q3 2022	share	1.72%	12.64M	$17.62	$8.28	-53.01%	Bought +410.02% shares Q3 2022
Biotechnology Amylyx Pharmaceuticals, Inc. Portfolio share: 1.64% Portfolio value: 12.08M Avg. open price: N/A Current price: $38.55 P/L: N/A N/A Q3 2022	share	1.64%	12.08M	N/A	$38.55	N/A	N/A Q3 2022
Diagnostics & Research Natera, Inc. Portfolio share: 1.64% Portfolio value: 12.08M Avg. open price: $73.98 Current price: $40.39 P/L: -45.41% Bought +109.04% shares Q3 2022	share	1.64%	12.08M	$73.98	$40.39	-45.41%	Bought +109.04% shares Q3 2022
Medical Devices Inspire Medical Systems, Inc. Portfolio share: 1.62% Portfolio value: 11.95M Avg. open price: $240.65 Current price: $234.96 P/L: -2.36% Sold -24.23% shares Q3 2022	share	1.62%	11.95M	$240.65	$234.96	-2.36%	Sold -24.23% shares Q3 2022
Medical Devices Cutera, Inc. Portfolio share: 1.58% Portfolio value: 11.66M Avg. open price: $46.6 Current price: $51.65 P/L: +10.84% Sold -0.70% shares Q3 2022	share	1.58%	11.66M	$46.6	$51.65	+10.84%	Sold -0.70% shares Q3 2022
Biotechnology DICE Therapeutics, Inc. Portfolio share: 1.48% Portfolio value: 10.85M Avg. open price: $25.16 Current price: $34.51 P/L: +37.16% Sold -34.37% shares Q3 2022	share	1.48%	10.85M	$25.16	$34.51	+37.16%	Sold -34.37% shares Q3 2022
Medical Devices CVRx, Inc. Portfolio share: 1.34% Portfolio value: 9.88M Avg. open price: $18.41 Current price: $13.5 P/L: -26.69% Bought +10.07% shares Q2 2022	share	1.34%	9.88M	$18.41	$13.5	-26.69%	Bought +10.07% shares Q2 2022
Biotechnology Iovance Biotherapeutics, Inc. Portfolio share: 1.33% Portfolio value: 9.82M Avg. open price: $11.04 Current price: $8.03 P/L: -27.26% Bought +42.47% shares Q3 2022	share	1.33%	9.82M	$11.04	$8.03	-27.26%	Bought +42.47% shares Q3 2022
Medical Devices NeuroPace, Inc. Portfolio share: 1.19% Portfolio value: 8.75M Avg. open price: $18.05 Current price: $1.58 P/L: -91.25% Bought +0.43% shares Q2 2022	share	1.19%	8.75M	$18.05	$1.58	-91.25%	Bought +0.43% shares Q2 2022
Biotechnology Vericel Corporation Portfolio share: 1.18% Portfolio value: 8.67M Avg. open price: $15.95 Current price: $22.7 P/L: +42.30% N/A Q3 2022	share	1.18%	8.67M	$15.95	$22.7	+42.30%	N/A Q3 2022
Biotechnology Vaxcyte, Inc. Portfolio share: 1.09% Portfolio value: 8.05M Avg. open price: $22.14 Current price: $44.33 P/L: +100.21% Sold -9.44% shares Q3 2022	share	1.09%	8.05M	$22.14	$44.33	+100.21%	Sold -9.44% shares Q3 2022
Diagnostics & Research Castle Biosciences, Inc. Portfolio share: 1.06% Portfolio value: 7.76M Avg. open price: N/A Current price: $24.41 P/L: N/A N/A Q3 2022	share	1.06%	7.76M	N/A	$24.41	N/A	N/A Q3 2022
Medical Devices Inari Medical, Inc. Portfolio share: 1.00% Portfolio value: 7.38M Avg. open price: $67.99 Current price: $71.11 P/L: +4.59% Bought +40.54% shares Q3 2022	share	1.00%	7.38M	$67.99	$71.11	+4.59%	Bought +40.54% shares Q3 2022
Medical Devices TransMedics Group, Inc. Portfolio share: 0.99% Portfolio value: 7.31M Avg. open price: N/A Current price: $61.9 P/L: N/A Sold -4.96% shares Q3 2022	share	0.99%	7.31M	N/A	$61.9	N/A	Sold -4.96% shares Q3 2022
Healthcare Plans Humana Inc. Portfolio share: 0.94% Portfolio value: 6.89M Avg. open price: N/A Current price: $547.42 P/L: N/A N/A Q3 2022	share	0.94%	6.89M	N/A	$547.42	N/A	N/A Q3 2022
Biotechnology Nurix Therapeutics, Inc. Portfolio share: 0.89% Portfolio value: 6.56M Avg. open price: $29.97 Current price: $12.38 P/L: -58.69% Sold -49.31% shares Q3 2022	share	0.89%	6.56M	$29.97	$12.38	-58.69%	Sold -49.31% shares Q3 2022
Biotechnology Inhibrx, Inc. Portfolio share: 0.89% Portfolio value: 6.53M Avg. open price: $32.97 Current price: $29.18 P/L: -11.50% N/A Q3 2022	share	0.89%	6.53M	$32.97	$29.18	-11.50%	N/A Q3 2022
Medical Instruments & Supplies Intuitive Surgical, Inc. Portfolio share: 0.89% Portfolio value: 6.52M Avg. open price: N/A Current price: $269.72 P/L: N/A N/A Q3 2022	share	0.89%	6.52M	N/A	$269.72	N/A	N/A Q3 2022
Biotechnology Enanta Pharmaceuticals, Inc. Portfolio share: 0.87% Portfolio value: 6.38M Avg. open price: $55.41 Current price: $43.06 P/L: -22.28% Bought +23.01% shares Q3 2022	share	0.87%	6.38M	$55.41	$43.06	-22.28%	Bought +23.01% shares Q3 2022
Medical Devices Apollo Endosurgery, Inc. Portfolio share: 0.85% Portfolio value: 6.26M Avg. open price: $7.17 Current price: $9.99 P/L: +39.26% Sold -65.21% shares Q3 2022	share	0.85%	6.26M	$7.17	$9.99	+39.26%	Sold -65.21% shares Q3 2022
Drug Manufacturers—General Biogen Inc. Portfolio share: 0.84% Portfolio value: 6.19M Avg. open price: $267.55 Current price: $292.75 P/L: +9.42% N/A Q3 2022	share	0.84%	6.19M	$267.55	$292.75	+9.42%	N/A Q3 2022
Biotechnology Keros Therapeutics, Inc. Portfolio share: 0.75% Portfolio value: 5.49M Avg. open price: N/A Current price: $50 P/L: N/A N/A Q3 2022	share	0.75%	5.49M	N/A	$50	N/A	N/A Q3 2022
Biotechnology Alnylam Pharmaceuticals, Inc. Portfolio share: 0.73% Portfolio value: 5.40M Avg. open price: $145.85 Current price: $226.4 P/L: +55.23% Bought +34.33% shares Q3 2022	share	0.73%	5.40M	$145.85	$226.4	+55.23%	Bought +34.33% shares Q3 2022
Biotechnology Adverum Biotechnologies, Inc. Portfolio share: 0.72% Portfolio value: 5.30M Avg. open price: $20.88 Current price: $0.66 P/L: -96.84% N/A Q3 2022	share	0.72%	5.30M	$20.88	$0.66	-96.84%	N/A Q3 2022
Medical Devices AxoGen, Inc. Portfolio share: 0.69% Portfolio value: 5.06M Avg. open price: $9.34 Current price: $10.93 P/L: +16.99% N/A Q3 2022	share	0.69%	5.06M	$9.34	$10.93	+16.99%	N/A Q3 2022
Biotechnology ESSA Pharma Inc. Portfolio share: 0.65% Portfolio value: 4.80M Avg. open price: $14.04 Current price: $3.47 P/L: -75.29% Sold -36.66% shares Q3 2022	share	0.65%	4.80M	$14.04	$3.47	-75.29%	Sold -36.66% shares Q3 2022
Biotechnology Pieris Pharmaceuticals, Inc. Portfolio share: 0.65% Portfolio value: 4.75M Avg. open price: $3.94 Current price: $0.99 P/L: -74.90% Bought +501.51% shares Q1 2022	share	0.65%	4.75M	$3.94	$0.99	-74.90%	Bought +501.51% shares Q1 2022
Diagnostics & Research Exact Sciences Corporation Portfolio share: 0.64% Portfolio value: 4.70M Avg. open price: $39.39 Current price: $45.55 P/L: +15.64% Bought +21.68% shares Q3 2022	share	0.64%	4.70M	$39.39	$45.55	+15.64%	Bought +21.68% shares Q3 2022
Specialty Industrial Machinery Enovis Corporation Portfolio share: 0.64% Portfolio value: 4.70M Avg. open price: N/A Current price: $56.45 P/L: N/A N/A Q3 2022	share	0.64%	4.70M	N/A	$56.45	N/A	N/A Q3 2022
Biotechnology Celcuity Inc. Portfolio share: 0.61% Portfolio value: 4.45M Avg. open price: $9.33 Current price: $8.06 P/L: -13.66% Bought +5.97% shares Q3 2022	share	0.61%	4.45M	$9.33	$8.06	-13.66%	Bought +5.97% shares Q3 2022
Biotechnology Xenon Pharmaceuticals Inc. Portfolio share: 0.47% Portfolio value: 3.49M Avg. open price: $13.55 Current price: $38.83 P/L: +186.47% Bought +29.07% shares Q3 2022	share	0.47%	3.49M	$13.55	$38.83	+186.47%	Bought +29.07% shares Q3 2022
Medical Devices Establishment Labs Holdings Inc. Portfolio share: 0.46% Portfolio value: 3.42M Avg. open price: N/A Current price: $68.77 P/L: N/A Sold -20.13% shares Q3 2022	share	0.46%	3.42M	N/A	$68.77	N/A	Sold -20.13% shares Q3 2022
Medical Devices Nevro Corp. Portfolio share: 0.46% Portfolio value: 3.35M Avg. open price: N/A Current price: $43.47 P/L: N/A N/A Q3 2022	share	0.46%	3.35M	N/A	$43.47	N/A	N/A Q3 2022
Biotechnology Imago BioSciences, Inc. Portfolio share: 0.44% Portfolio value: 3.20M Avg. open price: N/A Current price: $35.86 P/L: N/A N/A Q3 2022	share	0.44%	3.20M	N/A	$35.86	N/A	N/A Q3 2022
Biotechnology FibroGen, Inc. Portfolio share: 0.41% Portfolio value: 3.04M Avg. open price: N/A Current price: $16.19 P/L: N/A Sold -22.57% shares Q3 2022	share	0.41%	3.04M	N/A	$16.19	N/A	Sold -22.57% shares Q3 2022
Biotechnology Lyra Therapeutics, Inc. Portfolio share: 0.40% Portfolio value: 2.96M Avg. open price: $10.98 Current price: $3.39 P/L: -69.12% N/A Q2 2022	share	0.40%	2.96M	$10.98	$3.39	-69.12%	N/A Q2 2022
Biotechnology Mirum Pharmaceuticals, Inc. Portfolio share: 0.39% Portfolio value: 2.84M Avg. open price: N/A Current price: $18.33 P/L: N/A Sold -30.81% shares Q3 2022	share	0.39%	2.84M	N/A	$18.33	N/A	Sold -30.81% shares Q3 2022
Medical Instruments & Supplies OraSure Technologies, Inc. Portfolio share: 0.29% Portfolio value: 2.14M Avg. open price: $11.63 Current price: $5.06 P/L: -56.49% N/A Q3 2022	share	0.29%	2.14M	$11.63	$5.06	-56.49%	N/A Q3 2022
Medical Devices InMode Ltd. Portfolio share: 0.27% Portfolio value: 1.96M Avg. open price: $36.91 Current price: $36.66 P/L: -0.68% Sold -64.02% shares Q3 2022	share	0.27%	1.96M	$36.91	$36.66	-0.68%	Sold -64.02% shares Q3 2022
Medical Devices DexCom, Inc. Portfolio share: 0.26% Portfolio value: 1.92M Avg. open price: $522.41 Current price: $116.56 P/L: -77.69% Sold -49.54% shares Q3 2022	share	0.26%	1.92M	$522.41	$116.56	-77.69%	Sold -49.54% shares Q3 2022
Biotechnology 89bio, Inc. Portfolio share: 0.26% Portfolio value: 1.91M Avg. open price: N/A Current price: $8.34 P/L: N/A N/A Q3 2022	share	0.26%	1.91M	N/A	$8.34	N/A	N/A Q3 2022
Biotechnology Eiger BioPharmaceuticals, Inc. Portfolio share: 0.22% Portfolio value: 1.64M Avg. open price: $10.49 Current price: $4.14 P/L: -60.53% Sold -74.11% shares Q3 2022	share	0.22%	1.64M	$10.49	$4.14	-60.53%	Sold -74.11% shares Q3 2022
Biotechnology AnaptysBio, Inc. Portfolio share: 0.22% Portfolio value: 1.63M Avg. open price: N/A Current price: $28.65 P/L: N/A Sold -90.05% shares Q3 2022	share	0.22%	1.63M	N/A	$28.65	N/A	Sold -90.05% shares Q3 2022
Biotechnology Chinook Therapeutics, Inc. Portfolio share: 0.21% Portfolio value: 1.53M Avg. open price: N/A Current price: $22.77 P/L: N/A Sold -11.36% shares Q3 2022	share	0.21%	1.53M	N/A	$22.77	N/A	Sold -11.36% shares Q3 2022
Biotechnology Fate Therapeutics, Inc. Portfolio share: 0.20% Portfolio value: 1.50M Avg. open price: $60.07 Current price: $20.4 P/L: -66.04% Sold -65.38% shares Q3 2022	share	0.20%	1.50M	$60.07	$20.4	-66.04%	Sold -65.38% shares Q3 2022
Biotechnology CRISPR Therapeutics AG Portfolio share: 0.20% Portfolio value: 1.43M Avg. open price: $60.49 Current price: $52.11 P/L: -13.86% Sold -76.14% shares Q4 2021	share	0.20%	1.43M	$60.49	$52.11	-13.86%	Sold -76.14% shares Q4 2021
Biotechnology Novo Nordisk A/S Portfolio share: 0.19% Portfolio value: 1.40M Avg. open price: N/A Current price: $127.08 P/L: N/A N/A Q3 2022	share	0.19%	1.40M	N/A	$127.08	N/A	N/A Q3 2022
Biotechnology Verastem, Inc. Portfolio share: 0.19% Portfolio value: 1.39M Avg. open price: N/A Current price: $0.42 P/L: N/A N/A Q4 2021	share	0.19%	1.39M	N/A	$0.42	N/A	N/A Q4 2021
Biotechnology Xilio Therapeutics, Inc. Portfolio share: 0.18% Portfolio value: 1.32M Avg. open price: N/A Current price: $2.43 P/L: N/A Sold -4.99% shares Q2 2022	share	0.18%	1.32M	N/A	$2.43	N/A	Sold -4.99% shares Q2 2022
Biotechnology Y-mAbs Therapeutics, Inc. Portfolio share: 0.17% Portfolio value: 1.25M Avg. open price: $32.38 Current price: $4.43 P/L: -86.32% Sold -35.98% shares Q3 2022	share	0.17%	1.25M	$32.38	$4.43	-86.32%	Sold -35.98% shares Q3 2022
Biotechnology PepGen Inc. Portfolio share: 0.16% Portfolio value: 1.18M Avg. open price: N/A Current price: $14.98 P/L: N/A Sold -25.71% shares Q3 2022	share	0.16%	1.18M	N/A	$14.98	N/A	Sold -25.71% shares Q3 2022
BRIDGEBIO PHARMA INC Portfolio share: 0.16% Portfolio value: 1.15M Avg. open price: N/A Current price: N/A P/L: N/A N/A Q1 2021	share	0.16%	1.15M	N/A	N/A	N/A	N/A Q1 2021
Biotechnology Apellis Pharmaceuticals, Inc. Portfolio share: 0.12% Portfolio value: 915K Avg. open price: N/A Current price: $49.41 P/L: N/A N/A Q3 2022	share	0.12%	915K	N/A	$49.41	N/A	N/A Q3 2022
Biotechnology IO Biotech, Inc. Portfolio share: 0.11% Portfolio value: 781K Avg. open price: N/A Current price: $2.81 P/L: N/A Sold -56.04% shares Q3 2022	share	0.11%	781K	N/A	$2.81	N/A	Sold -56.04% shares Q3 2022
Biotechnology Immunic, Inc. Portfolio share: 0.10% Portfolio value: 758K Avg. open price: $9.62 Current price: $1.34 P/L: -86.07% Bought +37.14% shares Q1 2022	share	0.10%	758K	$9.62	$1.34	-86.07%	Bought +37.14% shares Q1 2022
Shell Companies DA32 Life Science Tech Acquisition Corp. Portfolio share: 0.07% Portfolio value: 487K Avg. open price: N/A Current price: $9.89 P/L: N/A Sold -50.00% shares Q2 2022	share	0.07%	487K	N/A	$9.89	N/A	Sold -50.00% shares Q2 2022
Biotechnology Pliant Therapeutics, Inc. Portfolio share: 0.06% Portfolio value: 443K Avg. open price: $7.01 Current price: $17 P/L: +142.51% Sold -95.67% shares Q3 2022	share	0.06%	443K	$7.01	$17	+142.51%	Sold -95.67% shares Q3 2022
Biotechnology Rocket Pharmaceuticals, Inc. Portfolio share: 0.05% Portfolio value: 404K Avg. open price: N/A Current price: $19.03 P/L: N/A Sold -92.05% shares Q3 2022	share	0.05%	404K	N/A	$19.03	N/A	Sold -92.05% shares Q3 2022
Biotechnology Viridian Therapeutics, Inc. Portfolio share: 0.05% Portfolio value: 400K Avg. open price: $18.49 Current price: $26.84 P/L: +45.16% Sold -97.68% shares Q3 2022	share	0.05%	400K	$18.49	$26.84	+45.16%	Sold -97.68% shares Q3 2022
Biotechnology Kezar Life Sciences, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $7.07 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$7.07	N/A	Sold -100.00% shares Q3 2022
Drug Manufacturers—Specialty & Generic Evolus, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $7.87 Current price: $6.98 P/L: -11.26% Sold -100.00% shares Q3 2022	share	0.00%	0	$7.87	$6.98	-11.26%	Sold -100.00% shares Q3 2022
Drug Manufacturers—General Horizon Therapeutics Public Limited Company Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $55.58 Current price: $98.48 P/L: +77.19% Sold -100.00% shares Q3 2022	share	0.00%	0	$55.58	$98.48	+77.19%	Sold -100.00% shares Q3 2022
Medical Instruments & Supplies NovoCure Limited Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $105.89 Current price: $78 P/L: -26.34% Sold -100.00% shares Q3 2022	share	0.00%	0	$105.89	$78	-26.34%	Sold -100.00% shares Q3 2022
Medical Devices STERIS plc Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $185.47 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$185.47	N/A	Sold -100.00% shares Q3 2022
Medical Devices Penumbra, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $212 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$212	N/A	Sold -100.00% shares Q3 2022
Biotechnology Incyte Corporation Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $84.08 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$84.08	N/A	Sold -100.00% shares Q3 2022
Medical Devices Outset Medical, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $21.42 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$21.42	N/A	Sold -100.00% shares Q3 2022
Medical Instruments & Supplies STAAR Surgical Company Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $56.43 Current price: $62.33 P/L: +10.45% Sold -100.00% shares Q3 2022	share	0.00%	0	$56.43	$62.33	+10.45%	Sold -100.00% shares Q3 2022
Drug Manufacturers—Specialty & Generic Supernus Pharmaceuticals, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $32.32 Current price: $35.61 P/L: +10.18% Sold -100.00% shares Q3 2022	share	0.00%	0	$32.32	$35.61	+10.18%	Sold -100.00% shares Q3 2022
Biotechnology ChemoCentryx, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $51.99 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$51.99	N/A	Sold -100.00% shares Q3 2022
Biotechnology Cullinan Oncology, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $11.61 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$11.61	N/A	Sold -100.00% shares Q3 2022
Household & Personal Products The Beauty Health Company Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $16.88 Current price: $11.03 P/L: -34.66% Sold -100.00% shares Q3 2022	call	0.00%	0	$16.88	$11.03	-34.66%	Sold -100.00% shares Q3 2022
Drug Manufacturers—General AstraZeneca PLC Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $55.83 Current price: $68.42 P/L: +22.55% Sold -100.00% shares Q3 2022	share	0.00%	0	$55.83	$68.42	+22.55%	Sold -100.00% shares Q3 2022
Medical Instruments & Supplies AngioDynamics, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $27.41 Current price: $12.06 P/L: -56.01% Sold -100.00% shares Q3 2022	share	0.00%	0	$27.41	$12.06	-56.01%	Sold -100.00% shares Q3 2022
Drug Manufacturers—Specialty & Generic Lantheus Holdings, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $21.74 Current price: $56.01 P/L: +157.59% Sold -100.00% shares Q3 2022	share	0.00%	0	$21.74	$56.01	+157.59%	Sold -100.00% shares Q3 2022
Biotechnology VistaGen Therapeutics, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $0.12 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$0.12	N/A	Sold -100.00% shares Q3 2022

Showing TOP 93 SOLEUS CAPITAL MANAGEMENT, L.P.'s 13F holdings.

Frequently Asked Questions (FAQ)

What is the biggest position of SOLEUS CAPITAL MANAGEMENT, L.P.?

The biggest position of the SOLEUS CAPITAL MANAGEMENT, L.P. is United Therapeutics Corporation (UTHR) with 6.68% portfolio share worth of 49.18M US dollars.

Top 5 SOLEUS CAPITAL MANAGEMENT, L.P.'s holdings represent 26.46% of the portfolio:

United Therapeutics Corporation (UTHR) – 6.68%
IVERIC bio, Inc. (ISEE) – 6.1%
EDAP TMS S.A. (EDAP) – 5.48%
The Beauty Health Company (SKIN) – 4.27%
Illumina, Inc. (ILMN) – 3.93%

Who is the portfolio manager of SOLEUS CAPITAL MANAGEMENT, L.P.?

The portfolio manager of the SOLEUS CAPITAL MANAGEMENT, L.P. is .

What is the total asset value of the SOLEUS CAPITAL MANAGEMENT, L.P. portfolio?

SOLEUS CAPITAL MANAGEMENT, L.P. total asset value (portfolio value) is 735.97M US dollars.

Who is ?

is the portfolio manager of the SOLEUS CAPITAL MANAGEMENT, L.P..

What is (SOLEUS CAPITAL MANAGEMENT, L.P.) fund performance?

SOLEUS CAPITAL MANAGEMENT, L.P.'s quarterly performance is +5.17%, annualy -40.94%.

What is the SOLEUS CAPITAL MANAGEMENT, L.P. CIK?

SOLEUS CAPITAL MANAGEMENT, L.P.'s Central Index Key is 0001802630 .